Groups | Route of administration | Treatmentsa | Mice number | ||
---|---|---|---|---|---|
 |  |  | Total mice | In HIband CMIc | In challenged |
I | Intramuscular vaccination | 100 μl PBS | 10 | 3 | 7 |
 |  | 100 μg pVAX1 | 10 | 3 | 7 |
 |  | 100 μg pVAX1-MEG-CTXA2/B | 10 | 3 | 7 |
II | Intranasal vaccination | 200 μl BRD509 | 10 | 3 | 7 |
 |  | 200 μl BRD509/pVAX1 | 10 | 3 | 7 |
 |  | 200 μl BRD509/pVAX1-MEG-CTXA2/B | 10 | 3 | 7 |
III | Intraoral vaccination | 50 μl BRD509 | 10 | 3 | 7 |
 |  | 50 μl BRD509/pVAX1 | 10 | 3 | 7 |
 |  | 50 μl BRD509/pVAX1-MEG-CTXA2/B | 10 | 3 | 7 |